Markets:

Overview

News

Currencies

International

Treasuries

SciSparc Ltd. - Ordinary Shares (NQ:SPRC)

6.850 +0.340 (+5.22%)

Streaming Delayed Price Updated: 3:40 PM EDT, Aug 19, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about SciSparc Ltd. - Ordinary Shares

< Previous 1 2

...

11 12 13 14 15 16 17 18 Next >

Cannabis Stock Movers For August 10, 2023 ↗

August 10, 2023

Via Benzinga

Topics Cannabis

Stocks That Hit 52-Week Lows On Thursday ↗

August 10, 2023

On Thursday, 128 companies set new 52-week lows.

Via Benzinga

Why SciSparc Shares Are Down 60% ↗

August 10, 2023

SciSparc Ltd (NASDAQ: SPRC) shares are trading lower by 59.8% to $0.20 Thursday morning after the company announced a proposed underwritten public offering of roughly $

Via Benzinga

Why Krispy Kreme Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

August 10, 2023

Gainers Edible Garden AG Incorporated (NASDAQ: EDBL) shares jumped 58% to $1.88 after the company reported better-than-expected second-quarter financial results.

Via Benzinga

SciSparc Ltd. Announces Pricing of $1.3 Million Underwritten Public Offering

August 10, 2023

From SciSparc Ltd

Via GlobeNewswire

Why AppLovin Shares Are Trading Higher By Over 22%; Here Are 20 Stocks Moving Premarket ↗

August 10, 2023

Gainers PHAXIAM Therapeutics S.A. (NASDAQ: PHXM) shares surged 46.7% to $0.64 in pre-market trading after gaining 6% on Wednesday.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

August 10, 2023

We're starting off the day with a breakdown of the biggest pre-market stock movers traders should watch on Thursday morning!

Via InvestorPlace

SciSparc Ltd. Announces Proposed Underwritten Public Offering of Approximately $1.3 Million

August 09, 2023

From SciSparc Ltd

Via GlobeNewswire

Marijuana Stock Movers For August 9, 2023 ↗

August 09, 2023

Via Benzinga

Topics Cannabis

Why EMCORE Shares Are Trading Higher By 17%; Here Are 20 Stocks Moving Premarket ↗

August 09, 2023

Gainers 180 Life Sciences Corp. (NASDAQ: ATNF) shares surged 109.2% to $1.58 in pre-market trading after falling over 6% on Tuesday.

Via Benzinga

Marijuana Stock Movers For August 8, 2023 ↗

August 08, 2023

Via Benzinga

Clearmind Medicine Files Patent Application with USPTO for the Treatment of Dyskinesia; Further Strengthens its Already Robust IP Portfolio

August 01, 2023

From Clearmind Medicine Inc.

Via GlobeNewswire

Cannabis Stock Movers For August 3, 2023 ↗

August 03, 2023

Via Benzinga

SciSparc and Clearmind Collaboration Continues to Increase its Patent Portfolio in the Field of Movement Abnormalities in the U.S.

August 01, 2023

From SciSparc Ltd

Via GlobeNewswire

Marijuana Stock Movers For August 2, 2023 ↗

August 02, 2023

Via Benzinga

EXCLUSIVE: Clearmind Medicine Files US Patent Application For Dyskinesia Treatment, Strengthening Its IP Portfolio ↗

August 01, 2023

Clearmind Medicine Inc (NASDAQ: CMND) has announced the filing of a provisional patent application for the treatment of Dyskinesia with the United States Patent and Trademark Office (USPTO) as part of...

Via Benzinga

Cannabis Stock Gainers And Losers From July 25, 2023 ↗

July 25, 2023

Via Benzinga

Marijuana Stock Movers For July 31, 2023 ↗

July 31, 2023

Via Benzinga

SciSparc to Commence Its Clinical Trial with SCI-210 in Children with Autism Spectrum Disorder

July 14, 2023

From SciSparc Ltd

Via GlobeNewswire

Cannabis Stock Gainers And Losers From July 28, 2023 ↗

July 28, 2023

Via Benzinga

SciSparc To Conduct Clinical Trial For Dronabinol-Based Drug To Treat Tourette Syndrome In Germany ↗

July 03, 2023

SciSparc Ltd. (NASDAQ: SPRC) has been granted an approval from the Federal Institute for Drugs and Medical Devices in Germany (“BfArM”) for its phase IIb clinical trial to use SCI-110 for treating...

Via Benzinga

SciSparc Receives Approval to Conduct Phase IIb Clinical Trial for SCI-110 to Treat Tourette Syndrome in Germany

June 30, 2023

From SciSparc Ltd

Via GlobeNewswire

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

June 28, 2023

We're starting off Wednesday with a breakdown of the biggest pre-market stock movers traders will want to keep an eye on!

Via InvestorPlace

SciSparc Announces IRB Approval to Conduct its Phase IIb Trial in Tourette Syndrome

June 21, 2023

From SciSparc Ltd

Via GlobeNewswire

EXCLUSIVE: SciSparc's Tourette Syndrome Candidate Receives IRB Approval To Start Phase 2b Study In US ↗

June 21, 2023

SciSparc Ltd (NASDAQ: SPRC) has received Institutional Review Board (IRB) approval for its Phase 2b clinical trial for SCI-110 in subjects suffering from Tourette Syndrome. Tourette Syndrome is a...

Via Benzinga

Clearmind Medicine and SciSparc to Conduct Study Evaluating Combination Treatment for Obesity and Metabolic Syndrome

June 16, 2023

From Clearmind Medicine Inc.

Via GlobeNewswire

SciSparc and Clearmind Medicine to Conduct a Study Evaluating Their Combination Treatment for Obesity and Metabolic Syndrome

June 16, 2023

From SciSparc Ltd

Via GlobeNewswire

Exclusive: Clearmind And SciSparc To Conduct Study Evaluating Psychedelics And CannAmide Based Drug For Treatment Of Obesity And Metabolic Syndrome ↗

June 16, 2023

Clearmind Medicine Inc. (NASDAQ: CMND) (CSE:CMND) (FSE:CWY) announced that as part of the company's ongoing collaboration with SciSparc Ltd.

Via Benzinga

The 7 Most Promising Penny Stocks to Buy in June ↗

June 07, 2023

These top penny stocks for June look to have legitimate catalysts that can certainly send share prices higher.

Via InvestorPlace

SciSparc Nutraceuticals Granted An Exclusive License For The Sales Of CannAmide On The Amazon Marketplace In Canada ↗

June 07, 2023

Jeffs' Brands Ltd (NASDAQ: JFBR), a data-driven e-commerce company operating on the Amazon Marketplace, announced that SciSparc Nutraceuticals Inc., in which the company owns a 49% equity interest, has...

Via Benzinga

< Previous 1 2

...

11 12 13 14 15 16 17 18 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.